Background: Diabetes mellitus accounts for 11% of total health expenditure worldwide, and most people with diabetes live in low-and middle-income countries. The present study examined the economic and social effects attributed to diabetes in Sudan by calculating out-of-pocket medical expenses and the health and social effects of the disease for people with diabetes (n = 375) and their families compared with a non-diabetic control group (n = 375), matched for age, sex, and residence area. Methods: Data were obtained in 2013 in four states within the Sudan, via structured interviews, using instruments from the International Diabetes Federation. Descriptive statistics were used to analyze differences between case and control participants. Results: The median total annual medical expenditure was fourfold higher for people with than without diabetes (US$579 vs US$148, respectively). Annual mean expenditure was 85% higher for those with diabetes (US$1004 vs US$544). People with diabetes were also significantly more likely to suffer from serious comorbidities, such as cardiovascular disorders and foot ulcers, compared with control participants. Moreover, those with diabetes reported a higher proportion of personal adverse social effects, such as being prevented from doing paid work or participating in education, both for themselves and their families. Conclusions: The high economic burden and adverse social effects on people with diabetes and their families in Sudan call for the development of evidencebased policy and program strategies for the prevention and management of diabetes, with an emphasis on low-resource communities.
Introduction
Diabetes poses major public health and socioeconomic challenges worldwide. The International Diabetes Federation (IDF) estimates that, globally, 415 million people, or 8.8% of adults aged 20-79 years, have diabetes, 1 of whom 75% live in low-and middleincome countries (LMICs). The number of adults with diabetes is expected to increase to 642 million people in 2040. 1 In high-income countries, approximately 90% of all people with diabetes are estimated to have type 2 diabetes. 1 The increases in the prevalence of diabetes are expected to be the largest in countries moving from low to middle income levels because of a gradually aging population and the adoption of a life style related to urbanization. 2 The prevalence of diabetes is expected to increase at an alarming rate in Africa.
It is estimated that approximately 20 million Africans are now living with diabetes, comprising a challenge for health systems at present and in the future. 2, 3 A recent study in Sudan reported that the overall crude prevalence of diabetes in north Sudan in 2016 was 19.1%, 3 much higher than the prevalence in 1998 (8.3%). 4 The economic burden of diabetes can be seen at a national level, within healthcare systems, and, perhaps most dramatically, at the family and individual level. Diabetes accounts for 11% of total health expenditure globally (US$548 billion). 1 This expenditure includes costs for healthcare systems, the families of people with diabetes, and the people with diabetes themselves. Compared with those living in high-income countries, people living in LMICs pay a larger share of diabetes health expenses, which is due primarily to a lack of health insurance and publicly available medical services. 1, 5 In the poorest countries, people with diabetes and their families assume almost the total cost of the associated medical care. 6, 7 Over the past decade there has been an increased focus on addressing noncommunicable diseases (NCDs), such as diabetes, worldwide. For example, Africa is facing an increased healthcare burden from the rapid rise in NCDs while still experiencing high rates of infectious disease. 8 Therefore, NCDs, including diabetes, threaten economic development and must be addressed at a global level. 1, 3 There are only a limited number of studies on the costs and social effects of living with diabetes in Sudan. In previous studies we showed that the economic burden of diabetes on patients and their families is substantial and disproportionate to the level of health care delivery. 6, 7 The prognosis of individuals with diabetes varies depending on the level of education and socioeconomic status. Further, illiteracy is likely to impede care. 6, 7 Therefore, the aim of the present study was to explore the economic and social effects attributed to diabetes in Sudan. To this end, data were collected to calculate: (i) out-of-pocket expenses for medical care, including medicines, by people with diabetes and their families; and (ii) socioeconomic effects on people with diabetes and their families compared with a control group without diabetes.
Methods

Study design
The present case-control study compared individuals with a diagnosis of diabetes mellitus with matched controls, based on age, sex, and geographic location. Data were obtained in 2013 via face-to-face structured interviews. The survey questionnaire and research instruments used were developed by the IDF. The primary investigator (HE) trained all interviewers in the interview protocol, as well as other study protocols. Case and control participants were asked the same set of interview questions, with the exception of a few questions for the cases about their diabetes treatment.
Ethical aspects
Each participant received verbal and written information of the aim of the study. Subjects were informed about confidentiality and that their participation would not in any way change their treatment at the clinic they were attending. Finally, subjects were told that they could decide to leave the study at any time and for any reason, which they would not be asked to disclose. The Ethics Committee of the Federal Ministry of Health in Sudan approved the study.
Interview protocol and cost estimates
The interviews covered self-reported health, access and use of medical services, payments for medical services, and effects of ill health on daily living (e.g. ability to work), and on family members, as well as other health problems. Estimates of expenditure on medical care, including medicines, all types of services, and other costs related to the utilization of services (e.g. transportation costs). Outpatient visit costs were reported separately for visits made by participants to specialist doctors or surgeons, primary care doctors, traditional healers, nurses, and health educators (e.g. a diabetes educator or community health worker). Annual rates of use of medical services were calculated by multiplying the number of self-reported visits for the proceeding 90 days by 4. For overnight admissions to hospital, participants were asked to recall their total point-of-service payment, including costs for medication and tests. To increase accuracy of recall, the interview questions asked only about events occurring during the past 90 days.
Interviewers asked participants about their most recent purchase of each of the medicines they were using at the time of the interview. An average daily medication price was calculated using data regarding the price paid during the most recent medication purchase, the number of pills or units of insulin purchased at one time, and the number of pills, or units of insulin, prescribed per day. This amount was then adjusted to account for self-reported weekly adherence to medication. The total daily costs were then multiplied by 365 in order to obtain annual medication expenditures per individual. All costs are reported in US$, according to the conversion rates of the Sudanese pound (SDG; US$1 = SDG 4.30) at the time of data collection (2013), determined by the Central Bank of Sudan.
Sample size and statistical power
Data to calculate statistical power for an economic study in sub-Saharan Africa were not available at the start of the study. However, a similar study in China 9 that used the IDF interview protocol used 500 cases and 500 controls; thus, in the present study we recruited a total of 750 participants (375 cases and 375 controls), which would make it possible to detect a statistically significant difference in proportions of 10% points or larger, with 90% power and at α = 0.05.
Case selection and recruitment
Cases were recruited from outpatient diabetes clinics in four separate states from different parts of Sudan (Darfur, Sennar, Khartoum, and Al Jazirah). Al Jazirah lies between the Blue Nile and the White Nile in the east-central region of the country. Darfur is located in western Sudan. Khartoum is the capital of Sudan and is located in the center of the country at the confluence of the White Nile and Blue Nile. Sennar is located in south-east Sudan. There is a diabetes center in each state, and these four centers deliver services to more than 70% of all patients receiving diabetes care in the study area. Research assistants visited each diabetes center 3 days per working week. All patients visiting in 1 day were given information about the study and invited to participate. If they agreed to take part in the study, a time and location for the in-person interview and contact information were collected. To be eligible for inclusion, subjects had to be between 20 and 79 years of age and have diabetes mellitus.
Control participants were matched to cases based on age (within 5 years), sex, and geographical residence. In addition, control participants could not have current or past self-reported or physician-diagnosed diabetes mellitus. Each participant with diabetes suggested control people matching the specified criteria. Contact information for each of these potential control participants was obtained from the case participant. To protect confidentiality, participants were assured that their private health information would not be shared with other participants.
The lists of five names of potential control subjects were then randomly ordered and the first in line was approached, either by telephone or home visit. If the first individual on the list was at home, the interviewer attempted to recruit the individual to the study, obtain consent, and complete the interview at that time. If the first individual on the list was not at home, the research staff secured telephone contact information for this person so that recruitment could occur by telephone at a later time. If the individual was at home but declined to participate in the study, the interviewer proceeded to contact the second individual on the list, and the same procedures were repeated until one of the people on the list agreed to participate in the study.
In the event that a case or control participant was not able to speak or sufficiently recall information for the interview, surrogate people were identified to complete the interview on behalf of the participant. If an interview started but could not be completed or rescheduled, that particular case or control was removed from the study sample and was replaced with another person. The interviewer terminated the interviews of all control subjects who indicated that they had been diagnosed with diabetes, or if the participant no longer wished to continue in the study.
Statistical analyses
All data were checked by the principal investigator (HE) for errors, and any necessary corrections were made before data entry. Data were entered into EPIDATA FILE version 3.1 (EpiData Association, Odense Denmark), which has built-in range and consistency checks. Frequency distributions were used to identify outliers. Statistical analysis was performed using SPSS version 17 (SPSS Inc., Chicago, IL, USA). Data are presented as the mean AE SEM or as median values with the interquartile range (IQR) for data with skewed distribution. Descriptive statistics were run for all variables, and unadjusted comparisons between case and control participants were made using the Mann-Whitney U-test for continuous variables. Wherever appropriate to determine the statistical significance between the groups, P < 0.05 two-sided was considered significant. The Chisquared test was used for discrete variables.
Results
Interviews were completed with 375 people with diabetes (75% response rate) who were included in the final dataset, together with their 375 controls. The mean age of the entire study cohort was 50 years, 61% were women and 44% lived in Khartoum state. Case participants had a lower education level, but the same employment status as controls (Table 1) . Case participants were significantly less likely to be married or cohabitating than control participants (67% vs 75%, respectively).
Because the cost data were skewed, median values (and IQR) are reported together with mean values ( Table 2 ). The median of total annual medical expenditure, including inpatient costs, costs for outpatient visits, and costs of medicines used, were fourfold higher for cases than for controls (US$579 vs US$148, respectively). Annual mean expenditure was 85% higher for cases than controls (US$1004 vs US$544, respectively). In particular, median expenditure was almost ninefold higher on outpatient services (US$345 vs US$40) and almost 10-fold higher on all types of medicines (US$59 vs US$6) for cases versus controls ( Table 2 ). The significant differences in expenditure between cases and controls were similar for men and women. The four regions from which subjects were recruited to the study represented urban and rural areas. The Khartoum region is the capital, representing an urban area, whereas the other three regions represent rural areas. Total costs in the urban area were significantly higher than in the rural area (P < 0.05) and there was no significant difference in total costs between the three rural areas (data not shown).
Across the three age groups (20-39, 40-59, and 60-79 years), cases spent significantly more on all medical costs than controls. In particular, costs for outpatient services and medicines were much higher for cases than controls in the 20-39 year age group.
Among participants with diabetes, 59% reported not receiving regular medical services due primarily to a lack of economic resources to cover the costs of care. Among participants requiring insulin, 48% reported not being able to afford the treatment. People with diabetes reported a higher prevalence of comorbid diseases and conditions, in particular cardiac diseases, hypertension, erectile dysfunction or loss of libido, kidney disease, peripheral neuropathy, foot or leg ulcer, and depression (Table 3) .
In addition, cases were significantly more likely to report a negative effect on all social indicators ( Table 4) . As a result of their diabetes, 21% of individuals reported being prevented from doing any or as much paid work as they would like (vs 6.1% of controls). There was a similar effect on family members of the cases (Table 4) . Moreover, participants with diabetes and their families were significantly more likely to report being prevented or limited in their ability to grow food and do farming and housework. Further compounding the problem, cases were fivefold more likely than controls to report being prevented from enrolling in training or school due to their diabetes (8.5% vs 1.6%, respectively; Table 4), potentially limiting future income. Approximately one-third of cases (32%) reported not getting enough to eat (vs 8.5% of controls), and one of five family members of cases (20%) were reported to have the same experience (vs 6.9% of controls; Table 4 ). Data are presented as n (%). 109 (572) 58 (152) 15 (73) 477 (1123) 206 (662) P-values were calculated using the Mann-Whitney U-test because the variables were not normally distributed and are given for comparisons between case and control participants.
The interquartile range (IQR) is presented as the difference between the median values for Quartiles 3+4 and Quartiles 1+2.
Discussion
People with diabetes in Sudan were found to have much higher total annual costs for medical services, including inpatient, outpatient, and medication expenses, than individuals without diabetes. People with diabetes also reported a higher prevalence of comorbid diseases and conditions, and higher proportions of adverse social effects on themselves and other family members. The largest differences in total costs between people with diabetes and their matched controls were found in the youngest age group. Reported total expenditure for health care services and medications among people with diabetes in Italy were almost fourfold higher than for individuals without diabetes. 10 A study from a high-income country (the US) found that the health care expenditure among people with diabetes was more than twofold higher than for people without diabetes. 11 In a Chinese study using similar IDF tools, total expenditure for medical care among people with diabetes was threefold higher and they received threefold more medications than people without diabetes, 9 whereas in Saudi Arabia the expenditure was found to be up to 10-fold higher. 12 In a previous study in 2010, we found that an average of US$175 was spent annually on diabetes care by people with diabetes in Sudan, which included the costs of drugs, urine and blood tests, visits to doctors, and transportation. 7 However, in the same study the percentage of people with diabetes who could afford insulin was similar to that in the present study (48% vs 52%). The substantial increase in expenses seen in the present study may be due, in part, to some improvement in the economic situation in Sudan and increased access to care. Other studies have found that the presence of household members with chronic illnesses (e.g. diabetes) leads to high health expenditures and even impoverishment; in Uganda, households with a family member suffering from a chronic illness were found to be threefold more likely to incur costs for health care than other households. 13 In a recent study from Nigeria, expenses for diabetes treatment were incurred through out-ofpocket payments, and the use of savings was the most common method of payment, followed by support from family members.
14 Cardiac diseases and some other health conditions are more likely to be present among people with diabetes than individuals without diabetes. The findings of the present study support previous studies that have found that diabetes is responsible for more than half of all non-traumatic lower limb amputations, 15 is one of the leading causes of visual impairment and blindness, and is the leading cause of renal failure in many Table 3 Comparison of self-reported doctor-diagnosed health conditions in case (diabetic) and control (non-diabetic) subjects Cases (n = 375) Controls (n = 375)
Pvalue
Heart attack, heart failure, or other heart disease 36 (9. Data are presented as n (%). P-values were calculated using Pearson's Chi-squared comparison test.
Table 4
Proportion of case (diabetic) and control (non-diabetic) subjects reporting that their health problems were affecting their or their family members' lives Cases (n = 375) Controls (n = 375)
Pvalue
Prevented or kept from doing any paid work or doing as much paid work as wanted 77 (21) LMICs. 16 Evidence from studies in India shows that diabetes patients with a comorbid condition spend more on medicines, admission charges, laboratory charges, and miscellaneous charges for food and travel. 17 The presence of more than one additional comorbid condition further escalate the cost burden. In addition, the average cost for diabetes care in a study from India was significantly higher for diabetes patients with hypertension. 17 Because diabetes is a chronic disease associated with comorbidities and complications, it has a substantial effect on the cost of care. The financial burden is higher for individuals who have diabetes and an associated comorbid condition than for those who have only diabetes. 18 In addition, in the present study, individuals with diabetes were threefold more likely to suffer from depression than people without diabetes. (The term "depression" in the present study refers to depressive symptoms, rather than depression as a clinical diagnosis.) These results are consistent with and strengthen the findings of previous studies on the association between diabetes and comorbid depression. 18, 19 For example, in Hungary, adults with diabetes were twice as likely to have comorbid depression as individuals without diabetes. 19 A study in Taiwan indicated that the prevalence of depression among community residents with type 2 diabetes mellitus in rural areas was 17%, 20 and in Bangladesh depression is a common comorbid health problem in individuals with type 2 diabetes, with more than one-third of patients reporting experienced depression. 21 The economic resources required for awareness raising, diagnosis, and treatment of diabetes without complications have been shown to be cost-effective compared with the socioeconomic burden imposed by blindness, kidney failure, or foot amputation. 22 A salient finding of the present study is that the social impact of diabetes was far-reaching for both people with diabetes and their families. As a result of the diabetes, people with diabetes had lower rates of employment compared with individuals without diabetes, and their families were more likely to cut work hours and had lower enrolment in training or school than families without a family member with diabetes. Furthermore, diabetic individuals were prevented or limited in their ability to grow food and do farming and housework. Similarly, a US study found that the probability of employment for women and men with diabetes was lower that that of people without diabetes. 23 In support of the findings of the present study, other studies have shown that families of children with diabetes are more likely to report work restriction, financial effects, and high medical expenses than families of children without special health care needs. 6, 23 Other recent studies have reported similar findings: hypoglycemic events caused absenteeism from work, greater impairment while at work, and decreased overall productivity at work compared with those who had never had a hypoglycemic event. 24, 25 Together the findings indicate that diabetes is responsible for work loss and work limitation. The finding regarding reduced ability to pursue education among cases in the present study was also found in our previous study, 6 which found that poor metabolic control was associated with a negative effect on educational attainment and school performance of children with diabetes. The collection and valuation of such non-medical, indirect costs was beyond the scope of the present study, although they would have had added value to the present study. This remains a limitation that may hopefully be better addressed in forthcoming studies.
Some limitations and strengths of the present study need to be considered. There is a potential for recall bias about costs associated with diabetes care and hospitalization, as well as a possible underestimation of the costs of inpatients and medication in the study population because subjects were recruited from those receiving ambulatory care. Patients with chronic complications of diabetes are usually seen in the tertiary care. Moreover, some patients' recall of cost for treatments may not be adequate because of illiteracy or because the medications were bought by their households. Because the recruitment of subjects was based on recommendations of diabetes patients, there is a possibility that this sample is biased. A more careful selection strategy would have included participants either from the community or from the rolls of a hospital (but without diabetes). The economic and societal burdens of type 1 and type 2 diabetes mellitus are also very different. However, this was not accounted for in the present study. A strength of the present study is that the protocol used for the selection of matched control subjects ensured that a suitable control group was selected based on demographic factors. Another strength of the study was the survey instrument used, which was developed by the IDF, and this strengthens the applicability of the findings to other settings. Furthermore, the guidelines from the IDF contain instructions for coding alongside each of the questions. Therefore, the administration of the survey was largely self-explanatory. Moreover, the appropriate sample size of the present study according to sampling standards should be 375 respondents. However, the target number was 500, because we anticipated an up to 25% drop-out rate based on our prior knowledge of a prevalent passive attitude of many communities towards research.
In conclusion, the negative economic and social effects of diabetes on individuals and their families, facing high out-of-pocket costs and challenges to keep or gain full employment, emphasizes the need for the development of focused, evidence-based policy and program strategies for this population. Such strategies could include reducing barriers to health care access, early detection and integration of essential standards for managing diabetes into primary health care, and identifying the economic burden on individuals and their families. Public medical services should be accessible. The health system needs to implement inexpensive, easy-to-use interventions, such as diabetes selfmanagement education. Community participation is essential; for example, by developing civil societies to advocate for patients' rights. Further expansion of health insurance would reduce the out-of-pocket expenditure for individuals with diabetes.
